Search

(GlobeNewswire) - As per The Business Research Companys Acromegaly Global Market Report 2024, the acromegaly market is on a rapid growth trajectory, with substantial increases anticipated in the coming years. [...]

LONDON, March 13, 2024 (GLOBE NEWSWIRE) -- As per The Business Research Company's Acromegaly Global Market Report 2024, the acromegaly market is on a rapid growth trajectory, with substantial increases [...]

(GlobeNewswire) - The global neuroendocrine tumor treatment market size is slated to expand at ~12% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD [...]

(GlobeNewswire) - The 'Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030' report has been added to ResearchAndMarkets.com's offering. The global somatostatin analogs market is expected to reach [...]

DUBLIN, Feb. 16, 2024 /PRNewswire/ -- The https://www.researchandmarkets.com/report/somatostatin-analogs?utm_source=CI&utm_medium=PressRelease&utm_code=pxlv3l&utm_campaign=1936955+-+Global+Somatostatin+Analogs+Market+Report+2024-2030+Featuring+Major+Players+-+Novartis%2c+Sun+Pharma%2c+Midatech+Pharma%2c+Ipsen+Pharma%2c+Chiasma%2c+Peptron%2c+Dauntless+Pharma%2c+Camurus%2c+Teva%2c+and+Pfizer&utm_exec=chdomspi report has been added toResearchAndMarkets.com's offering. The global somatostatin analogs market is expected to reach an estimated $8.3 billion by 2030 with [...]

New York: ReportLinker has issued the following news release: Reportlinker.com announces the release of the report 'Somatostatin Analogs Global Market Report 2023' , Camurus AB, Dauntless Pharmaceuticals Inc., Bayer AG, [...]

M2 PRESSWIRE-April 10, 2023-: Gastric Neuroendocrine Tumors Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies - Pharmathene Ltd, [...]

COMP Adopts Positive Opinion on Orphan Designation for Mycapssa(R) for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors DUBLIN, Ireland, and Boston MA, December 19, 2022 Amryt (Nasdaq: AMYT), [...]

DUBLIN: Research and Markets has issued the following news release: The 'Global Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of [...]

European Commission approves Mycapssa(R) for the treatment of Acromegaly Mycapssa(R) will be the first and only oral somatostatin analog approved in the EU Approval based on MPOWERED Phase 3 trial [...]

DUBLIN: Research and Markets has issued the following news release: The 'Global Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of [...]

DUBLIN -- The 'Global Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By Synthesis Technology, By Type of Manufacturers, [...]

Pune, Nov. 24, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ' https://www.globenewswire.com/Tracker?data=Hu5Yaoal14elm711hqTLPYo_vtowBdMlJp8OH-_WCkYr2tvSIxpz1SZAruWC_TsEiB0XGKPAys88dNPJ5oAoWQZicBnUXqZFQyNeFMtL8_h4O0EwNqpoXHWqgwtQIb6qObKQYcXVMEetbQLv6JBWFw== by Product Type (Disposable Auto-injectors, Reusable Auto-injectors), by Disease Indication (Rheumatoid Arthritis, Multiple [...]

M2 PRESSWIRE-November 21, 2022-: The Worldwide Peptide Therapeutics Industry is Expected to Reach $58.4 Billion by 2028 (C)1994-2022 M2 COMMUNICATIONS RDATE:21112022 The 'Global Peptide Therapeutics Market Size, Share & Industry [...]

COMP adopts positive opinion on Orphan Disease Designation for Mycapssa(R) for the treatment of Acromegaly DUBLIN, Ireland, and Boston MA, October 18, 2022 Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical [...]

(GlobeNewswire) - Amryt Receives Marketing Authorisation Approval and Orphan Drug Designation for Filsuvez in Great Britain UK MHRA approval follows on from recent European Commission approval of Filsuvez DUBLIN, Ireland, [...]

DUBLIN: Research and Markets has issued the following news release: The 'Somatostatin Analogs Market Intelligence Report - Global Forecast to 2027' report has been added to ResearchAndMarkets.com's offering. The Global [...]

DUBLIN -- The 'Somatostatin Analogs Market Intelligence Report - Global Forecast to 2027' report has been added to ResearchAndMarkets.com's offering. The Global Somatostatin Analogs Market is projected to reach USD [...]

M2 PRESSWIRE-July 18, 2022-: The Worldwide Somatostatin Analogs Industry is Projected to Reach $10 Billion by 2027 (C)1994-2022 M2 COMMUNICATIONS RDATE:18072022 The 'Somatostatin Analogs Market Intelligence Report - Global Forecast [...]

M2 PRESSWIRE-June 23, 2022-: Neuroendocrine Tumor Treatment Market Size, Share, and Global Market Forecast to 2029 (C)1994-2022 M2 COMMUNICATIONS RDATE:22062022 The Global Neuroendocrine Tumor Treatment Market is expected to grow [...]

(GlobeNewswire) - Amryt Announces Details of EMA Contingent Value Rights Payment DUBLIN, Ireland, and Boston MA, May 17, 2022 Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, [...]

(GlobeNewswire) - Amryt Announces Positive Interim Analysis Data From Open Label Phase of EASE Phase 3 Trial in EB Late-breaking oral presentation at the American Academy of Dermatology Annual meeting [...]

(GlobeNewswire) - Amryt Announces Successful Bioavailability Study for Mycapssa (octreotide capsules) Data supports a planned Phase 3 study in the treatment of carcinoid symptoms associated with Neuroendocrine Tumors (NET) Global [...]

(GlobeNewswire) - Amryt Completes $125 Million Non-Dilutive Debt Refinancing New Facilities Will Significantly Reduce Amryts Interest Expense and Cost of Capital and Extend Term Debt Maturity Through 2027 Further Strengthens [...]

(GlobeNewswire) - Amryt Issues Ordinary Shares and Total Voting Rights DUBLIN, Ireland, and Boston MA, August 19, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to [...]

New York, March 19, Mar 19, 2021 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global Somatostatin Analogs Industry' - https://www.reportlinker.com/p06032950/?utm_source=GNW In addition to being a [...]

New York City: Moody's Investors Service has issued the following news release: Moody's Investors Service ('Moody's') has assigned a B3 corporate family rating (CFR) and B3-PD probability of default rating [...]

Dublin, March 17, Mar 17, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Global Peptide Cancer Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2026' report has been added to [...]

M2 PRESSWIRE-January 27, 2021-: Acromegaly: Overview, Epidemiology, Market, Emerging Drugs and Key players (C)1994-2021 M2 COMMUNICATIONS RDATE:27012021 DelveInsight's 'Acromegaly Market Insights, Epidemiology, and Market Forecast-2030' report deliver an in-depth understanding [...]

SEATTLE: Coherent Market Insights has issued the following news release: According to Coherent Market Insights, the global neuroendocrine tumor treatment market is estimated to be valued at US$ 1,448.1 Mn [...]

SEATTLE, March 26, 2020 /PRNewswire/ -- According to Coherent Market Insights, the global neuroendocrine tumor treatment market is estimated to be valued at US$ 1,448.1 Mn in 2019 and is [...]